phosphorodiamidic acid has been researched along with warfarin in 1 studies
| Studies (phosphorodiamidic acid) | Trials (phosphorodiamidic acid) | Recent Studies (post-2010) (phosphorodiamidic acid) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 26 | 0 | 10 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | phosphorodiamidic acid (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, V; Cate, ML; Ghosh, C; Iversen, PL | 1 |
1 other study(ies) available for phosphorodiamidic acid and warfarin
| Article | Year |
|---|---|
Phosphorodiamidate morpholino antisense oligomers inhibit expression of human cytochrome P450 3A4 and alter selected drug metabolism.
Topics: Caco-2 Cells; Cisplatin; Coumarins; Cyclophosphamide; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Fluorescein; Fluorescent Dyes; Growth Inhibitors; Hepatocytes; Humans; Morpholines; Oligonucleotides, Antisense; Paclitaxel; Phosphorus Compounds; Substrate Specificity | 2002 |